Your session is about to expire
← Back to Search
Behavioral Intervention
Contingency Management for Stimulant Use Disorder (MIMIC2 Trial)
N/A
Waitlist Available
Led By Sara Becker
Research Sponsored by Northwestern University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 10 months
Awards & highlights
MIMIC2 Trial Summary
This trial will evaluate a multi-level implementation strategy to install contingency management for stimulant use in 10 public opioid treatment programs. It will measure outcomes, provide staff feedback & rigorously evaluate its effectiveness.
Who is the study for?
This trial is for adults who are currently receiving medication for opioid use disorders within the last 30 days and also use stimulants, as shown by self-report or positive tests. They must be actively managing patient cases and providing psychosocial support. It's not open to those under 18, unable to consent, or without electronic medical records.Check my eligibility
What is being tested?
The study is testing a strategy called Science of Service Laboratory designed to help opioid treatment programs implement contingency management for patients with stimulant use disorder. The effectiveness of this multi-level approach will be measured in terms of its adoption by staff and impact on patient outcomes.See study design
What are the potential side effects?
Since this trial focuses on implementing a service strategy rather than a drug, it does not have traditional side effects. However, there may be challenges related to adapting new practices that could affect staff performance and patient care.
MIMIC2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 10 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~10 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in percent of counselors delivering contingency management from pre-implementation to post-implementation
Change in percent of patients receiving contingency management from pre-implementation to post-implementation
Secondary outcome measures
Change in number of contingency management sessions
Change in the percent of toxicology screens negative for stimulants
MIMIC2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Science of Service Laboratory implementation strategyExperimental Treatment1 Intervention
The Science of Service Laboratory implementation strategy consists of: didactic training (contingency management workshops; monthly contingency management coaching calls), performance feedback (practice sessions and electronic medical record feedback); and facilitation (monthly facilitation calls).
Group II: Stepped wedge comparatorActive Control1 Intervention
Our hybrid trial uses a unidirectional crossover stepped wedge design. All sites cross over in the same direction from usual care to intervention. All sites therefore act as their own comparison prior to the sequential roll-out of the implementation strategy.
Find a Location
Who is running the clinical trial?
National Institute on Drug Abuse (NIDA)NIH
2,465 Previous Clinical Trials
2,618,557 Total Patients Enrolled
Stanford UniversityOTHER
2,387 Previous Clinical Trials
17,333,974 Total Patients Enrolled
Northwestern UniversityLead Sponsor
1,585 Previous Clinical Trials
917,155 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am under 18 and on medication for opioid use disorder.I am on medication for opioid use disorder and do not have electronic medical records.I am currently managing a group of patients.I am under 18 years old.I provide counseling support to patients using medication for opioid addiction.I started medication for opioid addiction in the last 30 days and have used stimulants recently.
Research Study Groups:
This trial has the following groups:- Group 1: Science of Service Laboratory implementation strategy
- Group 2: Stepped wedge comparator
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the geographic breadth of this clinical trial's management?
"The current clinical trial is seeking enrolment from 10 separate medical centres, located in Hartford, Manchester and Middletown. To minimise the necessity for long-distance travel, participants should choose to visit the clinic nearest them when joining this study."
Answered by AI
Are there any vacancies available for potential participants in this experiment?
"The clinicaltrial.gov website reports that this particular medical trial is not actively recruiting at the moment, as it was first posted on February 1st 2023 and most recently updated January 26th 2023. However, there are currently 958 other studies looking for participants to participate in their research."
Answered by AI
Popular Categories
Share this study with friends
Copy Link
Messenger